-       Report 
- December 2023
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- July 2024
-  155 Pages 
- Global 
   From       €3231EUR$3,613USD£2,842GBP 
      €3801EUR$4,250USD£3,344GBP 
            -       Report 
- July 2024
-  151 Pages 
- Global 
   From       €3231EUR$3,613USD£2,842GBP 
      €3801EUR$4,250USD£3,344GBP 
          -       Report 
- November 2023
-  178 Pages 
- Asia Pacific 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- June 2025
-  39 Pages 
- South Korea 
   From       €4468EUR$4,995USD£3,930GBP 
           -       Report 
- June 2025
-  39 Pages 
- Australia 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
             The biodegradable stent market is a subset of the larger stent market. Stents are medical devices used to treat narrowed or blocked arteries. Biodegradable stents are made of polymers that dissolve over time, allowing the artery to return to its natural state. This type of stent is beneficial for patients who require short-term support for their arteries.
Biodegradable stents are designed to be used in a variety of medical procedures, including coronary artery disease, peripheral artery disease,    and other cardiovascular diseases. They are also used in the treatment of aneurysms and other vascular diseases.
The biodegradable stent market is expected to grow due to the increasing prevalence of cardiovascular diseases and the need for minimally invasive treatments. Additionally, the development of new technologies and materials for biodegradable stents is expected to drive the market.
Some companies in the biodegradable stent market include Abbott, Biotronik, Biosensors International, Boston Scientific, and Medtronic. Show Less   Read more